In vitro activity (MICs and rate of kill) of AFN-1252, a novel FabI inhibitor, in the presence of serum and in combination with other antibiotics

類似資料

• Mode of Action, In Vitro Activity, and In Vivo Efficacy of AFN-1252, a Selective Antistaphylococcal FabI Inhibitor
  著者:: Kaplan, Nachum, 等
  出版事項: (2012)
• AFN-1252, a FabI Inhibitor, Demonstrates a Staphylococcus-Specific Spectrum of Activity
  著者:: Karlowsky, James A., 等
  出版事項: (2009)
• Pharmacokinetics, pharmacodynamics and efficacy of novel FabI inhibitor AFN-1252 against MSSA and MRSA in the murine thigh infection model
  著者:: Banevicius, Mary A, 等
  出版事項: (2013)
• Activity of AFN-1252, a novel FabI inhibitor, against Staphylococcus aureus in an in vitro pharmacodynamic model simulating human pharmacokinetics
  著者:: Tsuji, Brian T, 等
  出版事項: (2013)
• Resistance to AFN-1252 Arises from Missense Mutations in Staphylococcus aureus Enoyl-acyl Carrier Protein Reductase (FabI)
  著者:: Yao, Jiangwei, 等
  出版事項: (2013)